SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 300 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $26,885,000 | +95.0% | 158,221 | +32.4% | 0.04% | +55.2% |
Q1 2020 | $13,788,000 | +4.2% | 119,497 | +3.2% | 0.03% | +31.8% |
Q4 2019 | $13,228,000 | +37.8% | 115,773 | +3.0% | 0.02% | +22.2% |
Q3 2019 | $9,599,000 | +27.9% | 112,395 | +3.6% | 0.02% | +28.6% |
Q2 2019 | $7,508,000 | -4.5% | 108,486 | +1.0% | 0.01% | -6.7% |
Q1 2019 | $7,864,000 | +29.1% | 107,367 | -0.2% | 0.02% | +15.4% |
Q4 2018 | $6,093,000 | -29.3% | 107,536 | -3.8% | 0.01% | -23.5% |
Q3 2018 | $8,617,000 | +14.4% | 111,735 | -1.5% | 0.02% | +13.3% |
Q2 2018 | $7,530,000 | +33.8% | 113,415 | +5.5% | 0.02% | +25.0% |
Q1 2018 | $5,629,000 | +0.6% | 107,550 | +2.8% | 0.01% | +9.1% |
Q4 2017 | $5,597,000 | -4.6% | 104,611 | -3.0% | 0.01% | -15.4% |
Q3 2017 | $5,868,000 | +0.2% | 107,849 | -4.8% | 0.01% | 0.0% |
Q2 2017 | $5,859,000 | -21.6% | 113,248 | -4.7% | 0.01% | -23.5% |
Q1 2017 | $7,472,000 | +23.9% | 118,861 | +4.0% | 0.02% | +13.3% |
Q4 2016 | $6,033,000 | +6.6% | 114,331 | +9.1% | 0.02% | -6.2% |
Q3 2016 | $5,662,000 | +40.5% | 104,831 | +5.1% | 0.02% | +33.3% |
Q2 2016 | $4,031,000 | +15.0% | 99,748 | -0.2% | 0.01% | +9.1% |
Q1 2016 | $3,506,000 | -23.2% | 99,922 | -1.7% | 0.01% | -26.7% |
Q4 2015 | $4,563,000 | +25.3% | 101,662 | +7.7% | 0.02% | +25.0% |
Q3 2015 | $3,641,000 | -18.0% | 94,437 | +3.0% | 0.01% | -14.3% |
Q2 2015 | $4,439,000 | +39.1% | 91,716 | +1.6% | 0.01% | +55.6% |
Q1 2015 | $3,191,000 | +12.4% | 90,259 | +2.2% | 0.01% | +12.5% |
Q4 2014 | $2,838,000 | -14.1% | 88,339 | -0.6% | 0.01% | -20.0% |
Q3 2014 | $3,305,000 | -2.9% | 88,889 | -0.1% | 0.01% | 0.0% |
Q2 2014 | $3,405,000 | -14.0% | 89,012 | +2.4% | 0.01% | -16.7% |
Q1 2014 | $3,959,000 | +9.8% | 86,888 | -3.9% | 0.01% | +9.1% |
Q4 2013 | $3,607,000 | -17.1% | 90,428 | -8.9% | 0.01% | -15.4% |
Q3 2013 | $4,351,000 | +23.4% | 99,268 | -11.4% | 0.01% | +18.2% |
Q2 2013 | $3,525,000 | – | 112,037 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |